Group 1 - The insurance stocks have experienced significant declines, with China Life falling by 3.81% to HKD 33.82, Xinhua Insurance down by 3.6% to HKD 60.2, and China Pacific Insurance decreasing by 3.14% to HKD 38.24 [1] - The government plans to issue approximately CNY 200 billion in special bonds to inject capital into major insurance companies, including China Life and PICC, marking the first time special bonds will be used for this purpose [1] - According to Industrial Securities, there is a pressing need for capital supplementation among leading state-owned insurance companies due to the downward trend in the solvency system, which is expected to continue affecting solvency levels in the coming years [1] Group 2 - The solvency pressure in the insurance industry is exacerbated by the increased allocation of equities, which further strains already tight solvency conditions [1] - From a regulatory perspective, the capital injection may aim to mitigate tail risks within the industry [1]

复星联合健康方面解释称，实际资本较上季度末下降约4.3亿元，其中核心资本较上季度末下降约3.3亿 元，附属资本较上季度末下降约1亿元，主要是由于浮亏使得净资产减少所致；最低资本较上季度末上 升约1.1亿元，主要是由于业务增长带来的保险业务风险增加，以及各类资产配置导致的最低资本内部 结构变化。 【#复星联合健康保险2025年保费78.41亿元# 财务再保险拉升偿付能力】近日，复星联合健康保险发布 的2025年第四季度偿付能力报告显示，2025年其保险业务收入78.41亿元，净利润1.3亿元。最近两次风 险综合评级结果均为BB级。 截至2025年第四季度末，公司的综合偿付能力充足率为173.25%、核心偿付能力充足率为121.05%，其 中综合偿付能力充足率较上季度末下降约16.4个百分点，核心偿付能力充足率较上季度末下降约12.1个 百分点。 若不考虑与汉诺威再保险（百慕大）有限公司签订的财务再保险合同，2025 年第四季度核心偿付能力 充足率和综合偿付能力充足率将分别变更为99%和149%，分别下降22%和24%。#保险理赔[超话]# 中经 记者 陈晶晶 北京报道 值得一提的是，偿付能力报告披露，复星联合健 ...

中经记者 陈晶晶 北京报道 近日，复星联合健康保险发布的2025年第四季度偿付能力报告显示，2025年其保险业务收入78.41亿 元，净利润1.3亿元。最近两次风险综合评级结果均为BB级。 截至2025年第四季度末，公司的综合偿付能力充足率为173.25%、核心偿付能力充足率为121.05%，其 中综合偿付能力充足率较上季度末下降约16.4个百分点，核心偿付能力充足率较上季度末下降约12.1个 百分点。 复星联合健康方面解释称，实际资本较上季度末下降约4.3亿元，其中核心资本较上季度末下降约3.3亿 元，附属资本较上季度末下降约1亿元，主要是由于浮亏使得净资产减少所致；最低资本较上季度末上 升约1.1亿元，主要是由于业务增长带来的保险业务风险增加，以及各类资产配置导致的最低资本内部 结构变化。 值得一提的是，偿付能力报告披露，复星联合健康保险于2024年7月31日与汉诺威再保险（百慕大）有 限公司签署了《个人比例再保险合同》为财务再保险合同，该合同转移了公司保险风险与市场风险，无 资产真实转移，并通过了重大保险风险测试。 若不考虑与汉诺威再保险（百慕大）有限公司签订的财务再保险合同，2025 年第四季度核心偿 ...

来源：银瑞社 十周年，是个重要的节点。 这一年，代表着企业迈入全新的阶段，更是向外界展示业绩的好时机。 过去的2025年，泰康在线迈入十周年，竭尽全力实现业绩的突破。 从泰康在线2025年业绩报告，看到了这家互联网财险的努力。 一是，签单保费首次突破200亿元。 数据显示，泰康在线实现签单保费201.79亿元，较上年同期的145.41亿元增长了38.79%。其中，车险签 单保费38.24亿元，同比增长27.59%。 二是，净利大涨超800%。 2025年，泰康在线实现保险业务收入179.18亿元，同比增长27.45%，实现净利润4.63亿元，同比增长 804.95%，实现总投资收益率2.79%，同比增长250个百分点。 | 职务 | 姓名 | 任职资格批复文号 | 任职开始日期 | | --- | --- | --- | --- | | 临时负责人 | 方远近 | 副总经理:原保监许可(2016)5号 | 2025年11月17日 | | 副总经理 | 丁峻峰 | 原保监许可〔2016〕5号 | 2016年3月4日 | | 副总经理 总精算师 | 黄立虎 | 副总经理:原银保监许可〔2018〕367 号 总精算 ...

公司称将加快资本补充 当非上市人身险公司在2025年集体迎来"丰收季"，长生人寿交出的成绩单却不尽如人意。近日，长生人 寿发布的2025年四季度偿付能力报告显示，截至2025年四季度末，其核心偿付能力充足率为64.8%、综 合偿付能力充足率为79.7%。 根据监管规定，保险公司必须同时满足"核心偿付能力充足率不低于50%、综合偿付能力充足率不低于 100%、风险综合评级B类及以上"三项指标才算达标。显然，长生人寿的核心能力充足率已经十分接近 监管红线，综合偿付能力充足率已经完全不达标。 如果一家险企偿付能力不达标，不仅会面临声誉风险，还将面临监管谈话、高管限薪等监管措施。《保 险公司偿付能力管理规定》提出，对于核心偿付能力充足率低于50%或综合偿付能力充足率低于100% 的保险公司，监管部门应当对其采取以下全部措施：监管谈话；要求保险公司提交预防偿付能力充足率 恶化或完善风险管理的计划；限制董事、监事、高级管理人员的薪酬水平；限制向股东分红。 "对于当前的长生人寿来说，仅靠内生资本积累难以扭转局面，股东需实质性注资或引入战略投资 者。"中国投资协会上市公司投资专业委员会副会长支培元表示。 对于偿付能力不达标的 ...

Core Viewpoint - In 2025, despite a favorable overall performance in the insurance industry, Changsheng Life Insurance Company reported significant losses, raising concerns about its solvency and operational challenges [1][3]. Financial Performance - In 2025, Changsheng Life achieved insurance business revenue of 1.926 billion yuan, a year-on-year decrease of 32.39% [7]. - The company reported a net loss of 512 million yuan in 2025, which is a significant increase from a loss of 192 million yuan in 2024 [8]. Solvency Status - As of the end of Q4 2025, Changsheng Life's core solvency ratio was 64.8%, and its comprehensive solvency ratio was 79.7%, both below regulatory standards [3][4]. - Regulatory requirements state that insurance companies must maintain a core solvency ratio of at least 50% and a comprehensive solvency ratio of at least 100% to be considered compliant [3]. Capital Supplementation Efforts - The company is actively working on capital supplementation, with shareholders accelerating arrangements to improve solvency [4][5]. - The last capital increase occurred in July 2015, raising registered capital from 1.3 billion yuan to 2.167 billion yuan [5]. Investment Challenges - Changsheng Life has faced significant investment losses, including a 290 million yuan impairment on a real estate debt investment and a 210 million yuan impairment on another investment project [8][9]. - The company has reported multiple investment losses in recent years, which have adversely affected its solvency ratios [9]. Strategic Focus - To address its challenges, Changsheng Life aims to improve profitability and reduce losses through various strategies, including optimizing cost structures and enhancing new business sales [9].

来源：中保新知 国内大型险企或首次迎来特别国债注资。 据媒体消息，中国大型保险公司将迎来2000亿元特别国债的注资，相关计划最早可能于今年一季度公 布。如果消息属实并落地，这将是我国首次通过发行特别国债向险企注资。 事实上，早在2025年5月7日国新办发布会上，金融监管总局局长李云泽就曾透露，"金融监管总局引导 行业深入推进降本增效可持续发展的基础进一步夯实，完善资本补充机制，大型商业银行资本补充工作 正在加快实施，大型保险集团资本补充已经提上日程，各地也正在多渠道有序补充中小金融机构资本 金，这些措施将进一步增强金融体系的韧性和服务高质量发展的能力"。 2025年，四大国有银行就已经先行迎来特别国债注资。如今，市场传出特别国债注资大型保险机构似乎 也并不意外。 01 特别国债开闸 有外媒消息称，中国2000亿元特别国债将用来为头部保险公司注入资本，包括中国人寿、中国人保、中 国太平等国有险企。 有业内人士表示，大型险企未来或将承担更多责任协助处置弱资质同业的风险，而监管也一直在推动包 括险资在内的中长期资金入市。 事实上，中国在2025年已经发行5000亿元特别国债为中国银行、中国建设银行、交通银行、中国邮 ...

陆家嘴国泰人寿官网显示，自2022年11月10日起，龚志荣兼任首席投资官职务。自2026年1月1日起，龚志荣免兼首席投资官职务。胡习兼任首席投资官职 务。 近期，陆家嘴国泰人寿官网披露公司高管变动情况，总经理龚志荣不再兼任首席投资官，由副总经理兼财务负责人胡习兼任该职务。 这已是陆家嘴国泰人寿近期第二起高管人事变动。2025年11月，陆家嘴国泰人寿时任董事会秘书、合规负责人、首席风险官郑洲晋升副总经理。 2025年陆家嘴国泰人寿偿付能力下滑。截至2025年三季度末，该公司核心偿付能力充足率从上季末的139.87%下降至121.64%，减少18.23个百分点；综合偿 付能力充足率从上季末的178.57%下降至162.60%，减少15.97个百分点。 ...

Group 1 - The core focus of the article is the leadership change at Jiaoyin Life Insurance, with Li Ya appointed as the new chairman, marking a significant shift for the traditionally low-profile company [2][21][24] - Li Ya has a long history with the company, having joined the Bank of Communications in 1991 and worked her way up through various positions, showcasing a strong background in retail and corporate banking [5][25][26] - Jiaoyin Life Insurance, established in January 2010, is the first bank-controlled life insurance company in China, with a registered capital of 5.1 billion yuan, where Bank of Communications holds 62.5% and MS&AD Insurance Group holds 37.5% [7][26] Group 2 - Jiaoyin Life Insurance reported significant growth in its insurance business, with a premium income of 17.86 billion yuan for the year, reflecting an 8.24% year-on-year increase driven by the growth of dividend life insurance [10][30] - The company achieved a net profit of 1.54 billion yuan for the year, representing a 38.77% increase compared to the previous year, with total assets reaching 166.74 billion yuan [10][30] - Despite high profitability, the company faces challenges, including a decline in solvency ratios and an increase in the surrender rate, which rose to 1.43% in the third quarter of 2025 from 0.94% in the previous quarter [14][32][34] Group 3 - Jiaoyin Life Insurance has been relatively quiet in terms of public disclosures, but it recently released a claims service report, indicating that it served over 60,000 clients in 2025 with total claims exceeding 400 million yuan [9][28] - The average time from claim application to payment was 1.03 days, with a claim approval rate of 99.8%, highlighting the company's efficiency in claims processing [10][28] - The company’s traditional life insurance business remains its primary revenue source, with a stable sales channel structure heavily reliant on bank insurance channels [12][30]

Leadership Changes - Li Ya has officially taken over as the Chairman and Director of China Everbright Life Insurance as of January 14, 2026, following the approval from the regulatory authority [4] - Wang Qingyan has stepped down from her roles as Director and Chairman of the company [4] Company Performance - For the first three quarters of 2025, China Everbright Life Insurance reported an insurance business revenue of 17.859 billion yuan, marking an 8.24% year-on-year increase [3][7] - The net profit for the same period reached 1.538 billion yuan, reflecting a significant year-on-year growth of 38.43% [3][7] - Investment income and fair value changes totaled 3.731 billion yuan, surpassing the total for the entire year of 2024 [3][7] Financial Metrics - As of September 30, 2025, the total assets of China Everbright Life Insurance amounted to 166.736 billion yuan, a 1.83% increase from the beginning of the year [8] - The net assets exceeded 10 billion yuan, reaching 10.057 billion yuan, which is a 75.45% increase year-to-date [8] - The investment yield for the first nine months of 2025 was 3.77%, while the comprehensive investment yield was lower at 1.91% [8] Solvency and Risk - The core solvency adequacy ratio and comprehensive solvency adequacy ratio were reported at 130.69% and 214.31%, respectively, as of the end of Q3 2025, showing a decline from the previous quarter [8] - The company has experienced a slight increase in the surrender rate for some products, with the annual cumulative surrender scale for certain insurance products reaching 888 million yuan [8]